Uploaded June 2026 | Updated September 2026, 2 hours ago
The closest thing to the Ozempic revolution is the invention of the smartphone—for better and for worse. It's a miracle drug that is giving people their lives back, but with tragic side effects. We dive into the good, bad and ugly of these drugs.
Viva Longevity is a non-profit channel whose mission is to find the best scientists and help them tell their stories.
PAPERS:
GLP-1 drugs combined with healthy lifestyle habits linked with reduced cardiovascular risk among diabetes patients
https://hsph.harvard.edu/news/glp-1-drugs-combined-with-healthy-lifestyle-habits-linked-with-reduced-cardiovascular-risk-among-diabetes-patients/
Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial
thelancet.com/journals/lancet/article/PIIS0140-6736(26)00656-2/fulltext
Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some Weight Loss
epicresearch.org/articles/two-years-after-stopping-glp-1s-most-patients-sustain-at-least-some-weight-loss
Most Patients with Type 2 Diabetes Maintain HbA1c Improvements a Year After Stopping GLP-1 Medications
epicresearch.org/articles/most-patients-with-type-2-diabetes-maintain-hba1c-improvements-a-year-after-stopping-glp-1-medications
0:00 The Ozempic revolution
2:49 Is culture why America is so obese?
7:59 Consumers fear vaccines love GLP-1 drugs
10:21 3 great GLP-1 books
16:32 3 GLP-1 books to be wary of
26:14 Review of Food Intelligence book
28:31 GLP-1 side effects
31:44 Does the weight come back?
The closest thing to the Ozempic revolution is the invention of the smartphone—for better and for worse. It's a miracle drug that is giving people their lives back, but with tragic side effects. We dive into the good, bad and ugly of these drugs.
Viva Longevity is a non-profit channel whose mission is to find the best scientists and help them tell their stories.
PAPERS:
GLP-1 drugs combined with healthy lifestyle habits linked with reduced cardiovascular risk among diabetes patients
https://hsph.harvard.edu/news/glp-1-drugs-combined-with-healthy-lifestyle-habits-linked-with-reduced-cardiovascular-risk-among-diabetes-patients/
Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial
thelancet.com/journals/lancet/article/PIIS0140-6736(26)00656-2/fulltext
Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some Weight Loss
epicresearch.org/articles/two-years-after-stopping-glp-1s-most-patients-sustain-at-least-some-weight-loss
Most Patients with Type 2 Diabetes Maintain HbA1c Improvements a Year After Stopping GLP-1 Medications
epicresearch.org/articles/most-patients-with-type-2-diabetes-maintain-hba1c-improvements-a-year-after-stopping-glp-1-medications
0:00 The Ozempic revolution
2:49 Is culture why America is so obese?
7:59 Consumers fear vaccines love GLP-1 drugs
10:21 3 great GLP-1 books
16:32 3 GLP-1 books to be wary of
26:14 Review of Food Intelligence book
28:31 GLP-1 side effects
31:44 Does the weight come back?
